Majid, Salmiya .

HRN: 06-68-02  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/24/2025
CO-AMOXICLAV 625MG (TAB)
04/24/2025
04/30/2025
P0
625mg
BID
G1P0 PU 39 3/7 Weeks AOG; T/c Dengue Fever With WS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: